Volume 144, Issue 1 pp. 19-23

Increased urinary leukotriene E4 excretion in patients with atopic dermatitis

T. Hishinuma

T. Hishinuma

Department of Pharmaceutical Sciences, Tohoku University Hospital and

Search for more papers by this author
N. Suzuki

N. Suzuki

Department of Pharmaceutical Sciences, Tohoku University Hospital and

Search for more papers by this author
S. Aiba

S. Aiba

Department of Dermatology,
Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan

Search for more papers by this author
H. Tagami

H. Tagami

Department of Dermatology,
Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan

Search for more papers by this author
M. Mizugaki

M. Mizugaki

Department of Pharmaceutical Sciences, Tohoku University Hospital and

Search for more papers by this author
First published: 07 July 2008
Citations: 26
Michinao Mizugaki. E-mail: [email protected]

Abstract

Background Synthesis of cysteinyl leukotrienes (LTs) is known to play a part in the pathogenesis of inflammatory diseases.

Objectives To define the involvement of cysteinyl LTs in atopic dermatitis (AD).

Methods Synthesis of cysteinyl LTs was assessed in patients with AD and healthy volunteers by measuring urinary LTE4, a useful index of systemic cysteinyl LT synthesis, using liquid chromatography/tandem mass spectrometry.

Results Mean ± SD urinary LTE4 levels in patients with AD (125 ± 69 pg mg−1 creatinine, n = 20) were significantly higher (P < 0·01) than in healthy volunteers (60 ± 19 pg mg−1 creatinine, n = 17). A significant correlation between urinary LTE4 and total serum IgE levels in patients with AD was observed (r = 0·643, P < 0·05).

Conclusions Our findings demonstrate an enhanced synthesis of cysteinyl LTs in patients with AD and suggest that cysteinyl LTs are involved in the pathophysiology of AD.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.